• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    5.07 Down 0.27(5.06%) Feb 5, 4:00PM EST
    |After Hours : 5.07 0.00 (0.00%) Feb 5, 4:57PM EST
    Prev Close:5.34
    Open:5.30
    Bid:4.79 x 300
    Ask:5.62 x 400
    1y Target Est:7.88
    Beta:1.64489
    Next Earnings Date:23-Feb-16ARIA Earnings announcement
    Day's Range:5.06 - 5.30
    52wk Range:4.72 - 10.07
    Volume:3,654,117
    Avg Vol (3m):3,426,840
    Market Cap:959.72M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 5.06%959.72M
    PFEUp 0.10%179.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.24
    Quarterly EPS Est (Dec-15) :-0.31
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback